Cocaine in Parotid Saliva, Blood and Urine - 4

This study has been completed.
Sponsor:
Collaborator:
Information provided by (Responsible Party):
James Cornish, University of Pennsylvania
ClinicalTrials.gov Identifier:
NCT00000190
First received: September 20, 1999
Last updated: March 1, 2013
Last verified: March 2013
  Purpose

The purpose of this study is to establish the use of parotid saliva as a means of detecting and quantifying cocaine and its metabolites.


Condition Intervention Phase
Cocaine-Related Disorders
Procedure: Parotid Gland
Phase 1

Study Type: Interventional
Study Design: Primary Purpose: Diagnostic
Official Title: Cocaine in Parotid Saliva, Blood and Urine

Resource links provided by NLM:


Further study details as provided by University of Pennsylvania:

Primary Outcome Measures:
  • Cocaine & benzoylecgonine content in saliva, plasma, & urine

Estimated Enrollment: 0
Study Start Date: January 1991
Study Completion Date: February 1992
Primary Completion Date: February 1992 (Final data collection date for primary outcome measure)
  Eligibility

Genders Eligible for Study:   Male
Accepts Healthy Volunteers:   No
Criteria

Please contact site for information.

  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00000190

Locations
United States, Pennsylvania
University of Pennsylvania
Philadelphia, Pennsylvania, United States, 19104 6178
Sponsors and Collaborators
University of Pennsylvania
Investigators
Principal Investigator: James Cornish, M.D. University of Pennsylvania
  More Information

No publications provided

Responsible Party: James Cornish, Principal Investigator, University of Pennsylvania
ClinicalTrials.gov Identifier: NCT00000190     History of Changes
Other Study ID Numbers: NIDA-00144-4, 3R01DA012268, K20-00144-4
Study First Received: September 20, 1999
Last Updated: March 1, 2013
Health Authority: United States: Federal Government

Additional relevant MeSH terms:
Cocaine-Related Disorders
Substance-Related Disorders
Mental Disorders

ClinicalTrials.gov processed this record on April 17, 2014